FDA Adverse Event Other Summary report: N

NOVOFINE 32

MDR report key: 2439535 · Received January 31, 2012

Report

Report Number
9681821-2012-00003
Event Type
Other
Date Received
January 31, 2012
Date of Event
January 1, 2011
Report Date
January 5, 2012
Manufacturer
NOVO NORDISK A/S, MEDICAL SYSTEMS
Product Code
FMI
PMA / PMN Number
K062500
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

NEEDLE BREAK IN SKIN AND NEEDED SURGERY TO REMOVE IT [INJURY ASSOCIATED WITH DEVICE]. CASE DESCRIPTION: THIS SPONTANEOUS CASE FROM THE UNIT STATES WAS REPORTED BY A CONSUMER AS "NEEDLE BROKE OFF IN THE SKIN AND NEEDED SURGERY TO REMOVE IT" AND CONCERNS A (B)(6) FEMALE PT USING NOVO FINE 32 NEEDLE FOR UNSPECIFIED PERIOD OF TIME DUE TO TYPE 2 DIABETES MELLITUS. PT'S HEIGHT: (B)(6). MEDICAL HISTORY INCLUDED TYPE 2 DIABETES MELLITUS. A PT REPORTED THAT ON ONE PARTICULAR OCCASION, SEVERAL MONTHS EARLIER, SHE NOTICED THAT A NEEDLE BROKE OFF IN HER ABDOMEN FOLLOWING AN INJECTION. SHE STATED THAT SHE REPLACED THE NEEDLE JUST PRIOR TO THE INJECTION BUT THAT SHE USUALLY LEAVES USED NEEDLES ATTACHED TO HER FLEXPEN IN BETWEEN INJECTION. SHE REPORTED THAT APPROXIMATELY TWO DAYS AFTER THE INCIDENT THE NEEDLE WAS REMOVED VIA A SURGICAL PROCEDURE PERFORMED IN HER PHYSICIAN'S OFFICE. IN ADDITION, THE PT REPORTED THAT SHE TYPICALLY "PERFORMED AIR SHOTS PRIOR TO ATTACHING A NEEDLE TO HER FLEXPEN." THE PT REPORTED THAT SHE WAS NOT CERTAIN OF THE BRAND AND SIZE OF THE NEEDLES SHE USED AT THE TIME OF THE EVENT. THE EVENT OF "INJURY ASSOCIATED WITH DEVICE" WAS REPORTED AS "RECOVERED" ON AN UNK DATE. NOTE: NOVOFINE 32 WAS CHOSEN AS SUSPECTED PRODUCT SINCE IT IS THE MOST WIDELY DISTRIBUTED NEEDLE BY NOVO NORDISK IN THE UNITED STATES. THE PT COULD NOT IDENTIFY EXACT BRAND OF NEEDLE USED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 NOVOFINE 32 NEEDLE FMI NOVO NORDISK A/S, MEDICAL SYSTEMS NA UNK

Patients

Seq Age Sex Outcome Treatment
1 66 YR Required Intervention LEVEMIR FLEXPEN (INSULIN DETEMIR) SOLUTION FOR| INJECTION, .0024 MOL/L ONGOING.